Improved survival albeit with persistent disparities in prognosis for people with cystic fibrosis in European countries
- PMID: 34598976
- DOI: 10.1183/13993003.01487-2021
Improved survival albeit with persistent disparities in prognosis for people with cystic fibrosis in European countries
Conflict of interest statement
Conflict of interest: C. Martin reports payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events from Chiesi and Zambon. Conflict of interest: P-R. Burgel reports consulting fees from AstraZeneca, Chiesi, GSK, Insmed, Vertex and Zambon, and payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events from Pfizer and Novartis.
Comment on
-
Survival estimates in European cystic fibrosis patients and the impact of socioeconomic factors: a retrospective registry cohort study.Eur Respir J. 2021 Oct 1;58(3):2002288. doi: 10.1183/13993003.02288-2020. Print 2021 Sep. Eur Respir J. 2021. PMID: 33678607
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical